LinusBio Introduces ClearStrand-ASD: Revolutionary Autism Diagnostic Aid Using Hair Analysis

LinusBio has launched ClearStrand-ASD, a novel diagnostic aid for autism spectrum disorder (ASD) that analyzes a single strand of hair3.

The test is designed to help physicians rule out ASD in children aged 1 to 36 months, with a negative predictive value (NPV) of 92.5%32.

ClearStrand-ASD uses proprietary robotics and lasers to analyze the metabolism of essential and non-essential elements over time in a hair strand3.

The test generates thousands of data points per patient, which are then analyzed using AI and machine learning to identify a molecular signature associated with ASD3.

Results are typically available within 3-4 weeks, potentially reducing the time to diagnosis and enabling earlier intervention2.

The test has shown consistency across different cultures and ethnicities, as demonstrated by studies in the U.S., U.K., Sweden, and Japan2.

ClearStrand-ASD is currently available in 44 U.S. states and must be ordered by a licensed healthcare provider32.

The test aims to address the current delay in ASD diagnosis, which has a median age of about four years old in the U.S.3

LinusBio's platform has potential applications beyond ASD, including other conditions such as ADHD and ALS2.

The company's technology has received FDA breakthrough designation for its innovative approach to ASD diagnosis1.

Sources:

1. https://globalgenes.org/raredaily/diagnosing-autism-with-a-single-strand-of-hair/

2. https://www.insideprecisionmedicine.com/topics/molecular-dx/with-one-strand-of-hair-linusbio-can-guide-autism-diagnosis-and-treatment/

3. https://njbmagazine.com/njb-news-now/linusbio-launches-autism-diagnostic-that-tests-single-strand-of-hair/